Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Cancers of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03301454
What this trial is testing

Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer, Squamous Cell
Centre Oscar Lambret 15
Not applicableNot Yet RecruitingNCT06756841
What this trial is testing

Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Energenx Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT00611754
What this trial is testing

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Sanofi 15
Testing effectiveness (Phase 2)Study completedNCT06010303
What this trial is testing

Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerEsophageal Squamous Cell CarcinomaEsophageal Squamous Cell Carcinoma by AJCC V8 Stage
BeiGene 118
Testing effectiveness (Phase 2)Study completedNCT02538510
What this trial is testing

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more
University of Washington 50
Testing effectiveness (Phase 2)UnknownNCT04602013
What this trial is testing

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 53
Testing effectiveness (Phase 2)Study completedNCT02499120
What this trial is testing

Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Pfizer 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06793761
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC

Who this might be right for
Head and Neck Cancer
Beijing Tongren Hospital 260
Early research (Phase 1)Study completedNCT02938273
What this trial is testing

Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
The Netherlands Cancer Institute 10
Large-scale testing (Phase 3)Study completedNCT01345682
What this trial is testing

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Boehringer Ingelheim 483
Testing effectiveness (Phase 2)Ended earlyNCT03254927
What this trial is testing

CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics 30
Not applicableStudy completedNCT04825873
What this trial is testing

Assess Safety of Nivolumab in Routine Oncology Practice in China

Who this might be right for
Non-Small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck
Bristol-Myers Squibb 3,102
Testing effectiveness (Phase 2)Study completedNCT00410826
What this trial is testing

Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+7 more
University of Washington 204
Testing effectiveness (Phase 2)Ended earlyNCT00352118
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT05977907
What this trial is testing

Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT04225364
What this trial is testing

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaImmunotherapy
Guangzhou Institute of Respiratory Disease 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT03323463
What this trial is testing

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Neck
Memorial Sloan Kettering Cancer Center 316
Testing effectiveness (Phase 2)Study completedNCT04282109
What this trial is testing

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 141
Testing effectiveness (Phase 2)Study completedNCT00617734
What this trial is testing

Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck

Who this might be right for
Head and Neck Cancer
Eli Lilly and Company 97
Next Page